Kangmei Pharmaceutical Co (SHSE:600518) EPS (Basic) : ¥0.01 (TTM As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Kangmei Pharmaceutical Co EPS (Basic)?

Kangmei Pharmaceutical Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2024 was ¥0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.01.

Kangmei Pharmaceutical Co's EPS (Diluted) for the three months ended in Mar. 2024 was ¥0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.01.

Kangmei Pharmaceutical Co's EPS without NRI for the three months ended in Mar. 2024 was ¥-0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was 0.00.

During the past 3 years, the average EPS without NRI Growth Rate was 79.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Kangmei Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was 80.60% per year. The lowest was -36.30% per year. And the median was 31.40% per year.

Kangmei Pharmaceutical Co EPS (Basic) Historical Data

The historical data trend for Kangmei Pharmaceutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kangmei Pharmaceutical Co EPS (Basic) Chart

Kangmei Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

-0.99

-2.25

0.57

-0.19

0.01

Kangmei Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EPS (Basic)	Get a 7-Day Free Trial															-	-0.01	-	0.02	-

Kangmei Pharmaceutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Kangmei Pharmaceutical Co's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(102.521	-	0)	/	10252.123
	=	0.01

Kangmei Pharmaceutical Co's Basic EPS for the quarter that ended in Mar. 2024 is calculated as

Basic EPS (Q: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(7.471	-	0)	/	7471.308
	=	0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.01

Kangmei Pharmaceutical Co (SHSE:600518) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Kangmei Pharmaceutical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Kangmei Pharmaceutical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Kangmei Pharmaceutical Co (SHSE:600518) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kangmei Pharmaceutical Co Ltd (SHSE:600518) » Definitions » EPS (Basic)

Traded in Other Exchanges

N/A

Address

No. 3, Taike Road, Xiameilin, Futian District, Shenzhen, CHN, 518000

Website

http://www.kangmei.com.cn

Kangmei Pharmaceutical Co Ltd is a pharmaceutical company engaged in the manufacturing, research and marketing of herbal medicine and chemical raw materials.

Executives

Xu Dong Jin	Director
Li Jian Hua	senior management
Qiu Xi Wei	Director
Wang Min	senior management
Peng Qin	senior management
Ma Xing Tian	Director
Lin Guo Xiong	senior management
Zhuang Yi Qing	senior management
Wen Shao Sheng	Supervisors

Kangmei Pharmaceutical Co (SHSE:600518) Headlines

No Headlines